Other Non-Operating Income, Net - Schedule of Other Non-Operating Income, Net (Details) - USD ($) $ in Thousands |
3 Months Ended | 12 Months Ended | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 29, 2026 |
Mar. 30, 2025 |
Dec. 28, 2025 |
Dec. 29, 2024 |
|||||||||||||||||||||||
| Schedule of Other income (Expense), Net [Line Items] | ||||||||||||||||||||||||||
| Change in fair value of derivative liabilities | $ 26,608 | [1] | $ 15,127 | [1] | $ 11,490 | [2] | $ 33,986 | [2] | ||||||||||||||||||
| Change in fair value of FACT public, private placement and working capital warrants | (615) | 1,092 | (2,800) | (1,258) | ||||||||||||||||||||||
| Loss on conversion of SAFE agreements to common stock with related party | (1,250) | |||||||||||||||||||||||||
| Change in fair value of SAFE Agreement with related party | (44) | (20) | (151) | 616 | ||||||||||||||||||||||
| Change in fair value of forward purchase agreement liabilities | (1,142) | [3] | 268 | [3] | (471) | [4] | 337 | [4] | ||||||||||||||||||
| Loss on issuance of derivative liabilities | [5] | (24,688) | ||||||||||||||||||||||||
| Other financing costs | (3,769) | |||||||||||||||||||||||||
| Other, net | (205) | [6] | 292 | [6] | 1,279 | [7] | (221) | [7] | ||||||||||||||||||
| Total Other non-operating income, net | $ 30,761 | [8] | $ 14,576 | [8] | 9,347 | [9] | 7,932 | [9] | ||||||||||||||||||
| Change in fair value of Carlyle warrants [Member] | ||||||||||||||||||||||||||
| Schedule of Other income (Expense), Net [Line Items] | ||||||||||||||||||||||||||
| Change in fair value | 2,869 | |||||||||||||||||||||||||
| Redeemable convertible preferred stock warrant liability [Member] | ||||||||||||||||||||||||||
| Schedule of Other income (Expense), Net [Line Items] | ||||||||||||||||||||||||||
| Change in fair value | $ 1,310 | |||||||||||||||||||||||||
| ||||||||||||||||||||||||||